SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-18-005147
Filing Date
2018-02-01
Accepted
2018-02-01 16:01:38
Documents
1
Group Members
DAVID N. SOSLAND TRUST ASOSLAND FAMILY TRUST B PARTNERSHIPSOSLAND FOUNDATION

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (AMENDMENT NO. 4) tv483556_sc13ga.htm SC 13G/A 90188
  Complete submission text file 0001144204-18-005147.txt   91648
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87380 | Film No.: 18566872
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 4800 MAIN STREET SUITE 100 KANSAS CITY MO 64112
Business Address
Sosland Morton I. (Filed by) CIK: 0001585668 (see all company filings)

Type: SC 13G/A